Improving health and social care through evidence-based guidance

Find NICE guidance

Browse guidance by area:

Conditions and diseases

Health and social care delivery

Health protection

Lifestyle and wellbeing

Population groups

Settings

  • About us
  • Put guidance into practice
  • Find journals and databases
  • Financial planning
  • Get involved

Latest guidance  

COVID-19 rapid evidence summary: Tocilizumab for COVID-19
Suspected neurological conditions: recognition and referral
Encorafenib plus cetuximab for previously treated BRAF V600E mutation-positive metastatic colorectal cancer
The PLASMA system for transurethral resection and haemostasis of the prostate
Artificial intelligence in mammography

Latest guidance in consultation  

Danis Stent for acute oesophageal variceal bleeds (MT450)
Ex-situ machine perfusion for extracorporeal preservation of lungs (ex - vivo lung perfusion) for transplantation
Transvaginal laser therapy for urogenital atrophy
Transvaginal laser therapy for stress urinary incontinence
Laser lithotripsy for difficult-to-treat bile duct stones

Explore NICE

  1. News|
  2. About|
  3. Events|
  4. Get involved

We're looking for a new deputy director of finance - strategy and commercial

Register to observe our January public board meeting via Zoom

NICE and LSE's MSc Evaluation of Health Care Interventions and Outcomes

Support for industry to engage with us during health technology development

Our role in patient safety

We’re co-hosting the Health Technology Assessment International Annual Meeting in June - find out more

Latest news  

  1. Treatment for men with enlarged prostate is recommended by NICE for NHS adoption
  2. NICE collaboration on streamlined licensing and patient access process for new medicines opened on January 1st
  3. Shared decision making is an integral part of healthcare, says NICE
  4. NICE, RCGP and SIGN publish guideline on managing the long-term effects of COVID-19

Tweets

by @NICEcomms
Tweets by NICEcomms
Tweets by NICEcomms